English

ORIC Pharmaceuticals, Inc.

EDGAR

ORIC Current report (8-K) · filed 2026-10-23

34 filing records in this dataset, filed from 2020-02-28 to 2026-10-23. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 37.5 million USD 2026-06-30 Source
Exact value

37483000 USD
Long-term debt including current maturities: 10.5 million USD 2021-12-31 Source
Exact value

10500000 USD
Shares outstanding: 104 million shares 2026-06-30 Source
Exact value

103636424 shares

Reported share-count change

20.25% · 17.4 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

86187328 shares · 2025-06-30· Source
103636424 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-140 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -32587000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -129468000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -98963000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -35767000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -41492000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-112 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -88487000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -63375000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -110970000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -88487000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -32438000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -64043000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -32438000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

620 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 485000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 450000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 712000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 485000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 2000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 358000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 2000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-112 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -88487000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -63375000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -110970000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -88487000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -32438000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -64043000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -32438000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 485000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 450000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 712000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 485000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 2000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 358000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 2000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-23.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2021-12-31
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 1.62 million

Prior period

−USD 127.85 million

2024-01-01 – 2024-12-31
Current period

−USD 129.47 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-129468000 − -127847000 = -1621000 USD

-127847000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-129468000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ORIC Pharmaceuticals, Inc. · 2025-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Year-over-year change in Net income: -1621000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -129468000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#2078956 Filing: 000119312526064005 Input fundies:NetIncome: -127847000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#2080798 Filing: 000119312526064005
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.69 million

Prior period

−USD 112.66 million

2024-01-01 – 2024-12-31
Current period

−USD 110.97 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-110970000 − -112662000 = 1692000 USD

-112662000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-110970000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ORIC Pharmaceuticals, Inc. · 2025-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Year-over-year change in Operating cash flow: 1692000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -110970000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1915308 Filing: 000119312526064005 Input fundies:OperatingCashFlow: -112662000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1917164 Filing: 000119312526064005
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-40.1%

Prior period

USD 1.19 million

2024-01-01 – 2024-12-31
Current period

USD 712,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

712000 − 1188000 = -476000 USD

1188000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
712000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ORIC Pharmaceuticals, Inc. · 2025-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Year-over-year change in Capital expenditure: -476000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 712000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1924454 Filing: 000119312526064005 Input fundies:CapitalExpenditure: 1188000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1926193 Filing: 000119312526064005
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 21.36 million Exact value Exact value: -21363000 USD 2018-01-01 – 2018-12-31: -21363000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORIC Pharmaceuticals, Inc. · 2018-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Net Income: -21363000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21363000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000156459021014865/oric-10k_20201231.htm#2842283 Filing: 000156459021014865 The citation records this snapshot. The page link may show a newer release later.	−USD 20.68 million Exact value Exact value: -20683000 USD 2018-01-01 – 2018-12-31: -20683000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORIC Pharmaceuticals, Inc. · 2018-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Operating Cash Flow: -20683000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20683000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000156459021014865/oric-10k_20201231.htm#2638361 Filing: 000156459021014865 The citation records this snapshot. The page link may show a newer release later.	USD 525,000 Exact value Exact value: 525000 USD 2018-01-01 – 2018-12-31: 525000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORIC Pharmaceuticals, Inc. · 2018-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Capital Expenditure: 525000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 525000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000156459021014865/oric-10k_20201231.htm#2654438 Filing: 000156459021014865 The citation records this snapshot. The page link may show a newer release later.	−USD 21.21 million Calculation and evidence -20683000 − 525000 USD Exact free cash flow: -21208000 USD 2018-01-01 – 2018-12-31: -20683000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 525000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORIC Pharmaceuticals, Inc. · 2018-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Free cash flow: -21208000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20683000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000156459021014865/oric-10k_20201231.htm#2638361 Filing: 000156459021014865 Input fundies:CapitalExpenditure: 525000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000156459021014865/oric-10k_20201231.htm#2654438 Filing: 000156459021014865 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 26.88 million Exact value Exact value: -26883000 USD 2019-01-01 – 2019-12-31: -26883000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORIC Pharmaceuticals, Inc. · 2019-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Net Income: -26883000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26883000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2442170 Filing: 000095017022004239 The citation records this snapshot. The page link may show a newer release later.	−USD 23.53 million Exact value Exact value: -23533000 USD 2019-01-01 – 2019-12-31: -23533000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORIC Pharmaceuticals, Inc. · 2019-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Operating Cash Flow: -23533000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23533000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2202967 Filing: 000095017022004239 The citation records this snapshot. The page link may show a newer release later.	USD 768,000 Exact value Exact value: 768000 USD 2019-01-01 – 2019-12-31: 768000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORIC Pharmaceuticals, Inc. · 2019-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Capital Expenditure: 768000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 768000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2216934 Filing: 000095017022004239 The citation records this snapshot. The page link may show a newer release later.	−USD 24.3 million Calculation and evidence -23533000 − 768000 USD Exact free cash flow: -24301000 USD 2019-01-01 – 2019-12-31: -23533000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 768000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORIC Pharmaceuticals, Inc. · 2019-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Free cash flow: -24301000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23533000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2202967 Filing: 000095017022004239 Input fundies:CapitalExpenditure: 768000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2216934 Filing: 000095017022004239 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 73.7 million Exact value Exact value: -73703000 USD 2020-01-01 – 2020-12-31: -73703000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORIC Pharmaceuticals, Inc. · 2020-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Net Income: -73703000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -73703000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2439987 Filing: 000095017022004239 The citation records this snapshot. The page link may show a newer release later.	−USD 45.27 million Exact value Exact value: -45268000 USD 2020-01-01 – 2020-12-31: -45268000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORIC Pharmaceuticals, Inc. · 2020-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Operating Cash Flow: -45268000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45268000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2200847 Filing: 000095017022004239 The citation records this snapshot. The page link may show a newer release later.	USD 667,000 Exact value Exact value: 667000 USD 2020-01-01 – 2020-12-31: 667000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORIC Pharmaceuticals, Inc. · 2020-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Capital Expenditure: 667000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 667000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2214937 Filing: 000095017022004239 The citation records this snapshot. The page link may show a newer release later.	−USD 45.94 million Calculation and evidence -45268000 − 667000 USD Exact free cash flow: -45935000 USD 2020-01-01 – 2020-12-31: -45268000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 667000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORIC Pharmaceuticals, Inc. · 2020-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Free cash flow: -45935000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45268000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2200847 Filing: 000095017022004239 Input fundies:CapitalExpenditure: 667000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm#2214937 Filing: 000095017022004239 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 78.72 million Exact value Exact value: -78715000 USD 2021-01-01 – 2021-12-31: -78715000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORIC Pharmaceuticals, Inc. · 2021-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Net Income: -78715000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -78715000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017023008483/oric-20221231.htm#2294955 Filing: 000095017023008483 The citation records this snapshot. The page link may show a newer release later.	−USD 59.54 million Exact value Exact value: -59541000 USD 2021-01-01 – 2021-12-31: -59541000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORIC Pharmaceuticals, Inc. · 2021-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Operating Cash Flow: -59541000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -59541000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017023008483/oric-20221231.htm#2119270 Filing: 000095017023008483 The citation records this snapshot. The page link may show a newer release later.	USD 939,000 Exact value Exact value: 939000 USD 2021-01-01 – 2021-12-31: 939000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORIC Pharmaceuticals, Inc. · 2021-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Capital Expenditure: 939000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 939000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017023008483/oric-20221231.htm#2130187 Filing: 000095017023008483 The citation records this snapshot. The page link may show a newer release later.	−USD 60.48 million Calculation and evidence -59541000 − 939000 USD Exact free cash flow: -60480000 USD 2021-01-01 – 2021-12-31: -59541000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 939000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORIC Pharmaceuticals, Inc. · 2021-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Free cash flow: -60480000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -59541000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017023008483/oric-20221231.htm#2119270 Filing: 000095017023008483 Input fundies:CapitalExpenditure: 939000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017023008483/oric-20221231.htm#2130187 Filing: 000095017023008483 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 89.12 million Exact value Exact value: -89122000 USD 2022-01-01 – 2022-12-31: -89122000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORIC Pharmaceuticals, Inc. · 2022-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Net Income: -89122000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -89122000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017024029298/oric-20231231.htm#1823485 Filing: 000095017024029298 The citation records this snapshot. The page link may show a newer release later.	−USD 75.14 million Exact value Exact value: -75143000 USD 2022-01-01 – 2022-12-31: -75143000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORIC Pharmaceuticals, Inc. · 2022-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Operating Cash Flow: -75143000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -75143000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017024029298/oric-20231231.htm#1688585 Filing: 000095017024029298 The citation records this snapshot. The page link may show a newer release later.	USD 2.08 million Exact value Exact value: 2078000 USD 2022-01-01 – 2022-12-31: 2078000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORIC Pharmaceuticals, Inc. · 2022-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Capital Expenditure: 2078000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2078000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017024029298/oric-20231231.htm#1695176 Filing: 000095017024029298 The citation records this snapshot. The page link may show a newer release later.	−USD 77.22 million Calculation and evidence -75143000 − 2078000 USD Exact free cash flow: -77221000 USD 2022-01-01 – 2022-12-31: -75143000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 2078000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORIC Pharmaceuticals, Inc. · 2022-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Free cash flow: -77221000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -75143000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017024029298/oric-20231231.htm#1688585 Filing: 000095017024029298 Input fundies:CapitalExpenditure: 2078000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017024029298/oric-20231231.htm#1695176 Filing: 000095017024029298 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 100.7 million Exact value Exact value: -100697000 USD 2023-01-01 – 2023-12-31: -100697000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORIC Pharmaceuticals, Inc. · 2023-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Net Income: -100697000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -100697000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017025022273/oric-20241231.htm#2009203 Filing: 000095017025022273 The citation records this snapshot. The page link may show a newer release later.	−USD 85.69 million Exact value Exact value: -85688000 USD 2023-01-01 – 2023-12-31: -85688000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORIC Pharmaceuticals, Inc. · 2023-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Operating Cash Flow: -85688000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -85688000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017025022273/oric-20241231.htm#1858670 Filing: 000095017025022273 The citation records this snapshot. The page link may show a newer release later.	USD 849,000 Exact value Exact value: 849000 USD 2023-01-01 – 2023-12-31: 849000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORIC Pharmaceuticals, Inc. · 2023-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Capital Expenditure: 849000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 849000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017025022273/oric-20241231.htm#1867058 Filing: 000095017025022273 The citation records this snapshot. The page link may show a newer release later.	−USD 86.54 million Calculation and evidence -85688000 − 849000 USD Exact free cash flow: -86537000 USD 2023-01-01 – 2023-12-31: -85688000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 849000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORIC Pharmaceuticals, Inc. · 2023-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Free cash flow: -86537000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -85688000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017025022273/oric-20241231.htm#1858670 Filing: 000095017025022273 Input fundies:CapitalExpenditure: 849000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000095017025022273/oric-20241231.htm#1867058 Filing: 000095017025022273 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 127.85 million Exact value Exact value: -127847000 USD 2024-01-01 – 2024-12-31: -127847000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORIC Pharmaceuticals, Inc. · 2024-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Net Income: -127847000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -127847000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#2080798 Filing: 000119312526064005 The citation records this snapshot. The page link may show a newer release later.	−USD 112.66 million Exact value Exact value: -112662000 USD 2024-01-01 – 2024-12-31: -112662000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORIC Pharmaceuticals, Inc. · 2024-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Operating Cash Flow: -112662000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -112662000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1917164 Filing: 000119312526064005 The citation records this snapshot. The page link may show a newer release later.	USD 1.19 million Exact value Exact value: 1188000 USD 2024-01-01 – 2024-12-31: 1188000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORIC Pharmaceuticals, Inc. · 2024-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Capital Expenditure: 1188000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1188000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1926193 Filing: 000119312526064005 The citation records this snapshot. The page link may show a newer release later.	−USD 113.85 million Calculation and evidence -112662000 − 1188000 USD Exact free cash flow: -113850000 USD 2024-01-01 – 2024-12-31: -112662000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1188000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORIC Pharmaceuticals, Inc. · 2024-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Free cash flow: -113850000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -112662000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1917164 Filing: 000119312526064005 Input fundies:CapitalExpenditure: 1188000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1926193 Filing: 000119312526064005 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 129.47 million Exact value Exact value: -129468000 USD 2025-01-01 – 2025-12-31: -129468000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORIC Pharmaceuticals, Inc. · 2025-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Net Income: -129468000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -129468000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#2078956 Filing: 000119312526064005 The citation records this snapshot. The page link may show a newer release later.	−USD 110.97 million Exact value Exact value: -110970000 USD 2025-01-01 – 2025-12-31: -110970000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORIC Pharmaceuticals, Inc. · 2025-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Operating Cash Flow: -110970000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -110970000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1915308 Filing: 000119312526064005 The citation records this snapshot. The page link may show a newer release later.	USD 712,000 Exact value Exact value: 712000 USD 2025-01-01 – 2025-12-31: 712000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORIC Pharmaceuticals, Inc. · 2025-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Capital Expenditure: 712000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 712000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1924454 Filing: 000119312526064005 The citation records this snapshot. The page link may show a newer release later.	−USD 111.68 million Calculation and evidence -110970000 − 712000 USD Exact free cash flow: -111682000 USD 2025-01-01 – 2025-12-31: -110970000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 712000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORIC Pharmaceuticals, Inc. · 2025-12-31 ORIC Pharmaceuticals, Inc. (edgar:1796280) Free cash flow: -111682000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1796280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -110970000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1915308 Filing: 000119312526064005 Input fundies:CapitalExpenditure: 712000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm#1924454 Filing: 000119312526064005 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

34 filings · 1,500 latest values · 1,500 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001796280, 1796280, ORIC, edgar:1796280

Also known as ORIC PHARMACEUTICALS, INC., ORIC Pharmaceuticals, Inc., Oric Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation